Multi-hit PIK3CA CRC tumors showed a higher prevalence of mutations in DNA damage response compared to unmutated PIK3CA tumors notably in BRCA2 (8.90% vs 2.00%, P < .001), and ATM (12.40% vs 4.60%, P < .001). This evidence concerns the gene PIK3CA and colorectal carcinoma.